Detection of Spirochetal DNA from Patients with Neuroborreliosis

Česká verzia

Authors: D. Pícha; L. Moravcová; D. Smíšková
Authors place of work: Klinika infekčních nemocí 2. LF UK a Nemocnice Na Bulovce, Praha
Published in the journal: Cesk Slov Neurol N 2016; 79/112(5): 566-571
Category: Původní práce

Summary

Aim:
To assess the importance of Borrelia burgdorferi sensu lato DNA verification in neuroborreliosis.

Material and methods:
Seventy-one hospitalized patients with clinically and laboratory-confirmed neuroborreliosis were included. PCR of plasma, urine and CSF was performed in parallel before and after the treatment, and after 3 and 6 months for plasma and urine. DNA was isolated using the QIAamp DNA Mini Kit, PCR was arranged as a two-step amplification (nested PCR). Each sample was examined by the five amplification systems in parallel: two were targeted at plasmide genes encoding OspA and OspC proteins and three at genes for 16S rDNA, flagellin and p66 protein.

Results:
Of all 71 patients, the specific DNA was found in 51 cases (71.8%) before treatment. After the treatment, the DNA was proven in 25 patients (35.2%). PCR positivity persisted in 19 (26.8%) after three months and still in five (7%) patients after six months. The highest frequency of PCR-positive results was obtained by the 16S rDNA system, slightly lower sensitivity was achieved with the OspA, OspC and flagellin primers and the lowest frequency of positives was in the p66 target.

Conclusion:
Borrelial DNA was most frequently found in CSF, less frequently in urine and the lowest number of positive results were in plasma. PCR positivity decreased gradually during the observation period, the test was still positive in some patients after six months. It is possible to recommend testing with a minimum of two target sequences to improve diagnostic sensitivity. Our results suggest that the PCR testing should only be used in neuroborreliosis as an supplementary diagnostic method and subject to correct clinical interpretation.

Key words:
neuroborreliosis – nested PCR – plasma – cerebrospinal fl uid – urine

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Zdroje

1. Dlouhý P, Honegr K, Krbková L, et al. Lymeská borrelióza – Doporučený postup v diagnostice, léčbě a prevenci. Klin Mikrobiol Inf Lék 2011; 17 (4): 144–53.

2. Ang CW, Notermans DW, Hommes M, et al. Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots. Eur J Clin Microbiol Infect Dis 2011; 30 (8): 1027–32. doi: 10.1007/s10096-011-1157-6.

3. Steere AC, McHugh G, Damle N, et al. Prospective study of serologic tests for Lyme Disease. Clin Infect Dis 2008; 47 (2): 188–95. doi: 10.1086/589242.

4. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 2007; 49 (10): 13–21.

5. Hulínská D, Votýpka J, Vaňousová D, et al. Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans. Folia Microbiol 2009; 54 (3): 246–56. doi: 10.1007/s12223- 0090039-0.

6. Berenová D, Krsek D, Šípová L, et al. Short-term stability of Borrelia garinii in cerebrospinal fluid. Folia Microbiol 2016; 61 (1): 45–50. doi: 10.1007/s12223-015-0408-9.

7. Forbes BA. Introducing a molecular test into the clinical microbiology laboratory: development, evaluation, and validation. Arch Pathol Lab Med 2003; 127 (9): 1106–11.

8. Lebech AM. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and strudies on taxonomic classification. APMIS Suppl 2002; 105: 1–40.

9. Nolte O. Nucleid acid amplification based diagnostic of Lyme (neuro-) borreliosis-lost in the jungle of methods, targets, and assays? Open Neurol J 2012; 6: 129–39. doi: 10.2174/1874205X01206010129.

10. Pícha D, Moravcová L, Žďárský E, et al. PCR in lyme neuroboreliosis: a prospective study. Acta Neurol Scand 2005; 112 (5): 287–92.

11. Pícha D, Moravcová L, Holečková D, et al. Examination of specific DNA by PCR in patients with different forms of Lyme borreliosis. Int J Dermatol 2008; 47 (10): 1004–10. doi: 10.1111/j.1365-4632.2008.03709.x.

12. Dumler JS. Molecular methods for ehrlichiosis and Lyme disease. Clin Lab Med 2003; 23 (4): 867–84.

13. Cerar T, Ogrinc K, Cimperman J, et al. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 2008; 46 (10): 3375–9. doi: 10.1128/JCM.00410-08.

14. Iyer R, Mukherjee P, Wang K, et al. Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol 2012; 51 (3): 857–62. doi: 10.1128/JCM.02785-12.

15. Hodzic E, Feng S, Holden K, et al. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother 2008; 52 (5): 1728–36. doi: 10.1128/AAC.01050-07.

16. Embers ME, Barthold SW, Borda JT, et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS ONE 2012; 7 (1): e29914. doi: 10.137/journal.phone0029 914.

17. Lantos PM, Auwaerter PG, Wormser GP. A systematic review of Borrelia burgdorferi morpfologic variants does not support a role in chronic Lyme disease. Clin Infect Dis 2014; 58 (4): 663–71. doi: 10.1093/cid/cit810.

18. Theisen M, Frederiksen B, Lebech AM, et al. Polymorphism in OspC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implication for taxonomy and for use of OspC protein as a diagnostic antigen. J Clin Microbiol 1993; 31 (10): 2570–6.

19. Pauluzzi P, Bonin S, Gonzalez Inchaurraga MA, et al. Detection of spirochaetal DNA simultaneously in skin biopsies, peripheral blood and urine from patients with erythema migrans. Acta Derm Venereol 2004; 84 (2): 106–10.

20. Bergmann AR, Schmidt BL, Derler AM, et al. Importance of sample preparation for molecular diagnosis of Lyme borreliosis from urine. J Clin Microbiol 2002; 40 (12): 4581–4.

21. Aberer E, Bergmann AR, Derler AM, et al. Course of Borrelia burgdorferi DNA shedding in urine after treatment. Acta Derm Venereol 2007; 87 (1): 39–42.